サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1442855

心臓再同期療法システムの世界市場：業界分析、規模、シェア、成長、動向、予測（2023年～2031年）

Cardiac Resynchronization Therapy Systems Market (Product Type: Cardiac Resynchronization Therapy Pacemaker and Cardiac Resynchronization Therapy Defibrillator) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 156 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
心臓再同期療法システムの世界市場：業界分析、規模、シェア、成長、動向、予測（2023年～2031年）
出版日: 2024年01月18日
発行: Transparency Market Research
ページ情報: 英文 156 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心臓再同期療法システム市場 - レポート対象範囲

世界の心臓再同期療法システム市場に関するTMRのレポートでは、過去と現在の成長動向、および2023年～2031年の予測期間中の市場指標の貴重な洞察を得る機会を調査しています。このレポートは、世界の心臓再同期療法システム市場の2017年～2031年の期間の収益を提供し、2023年を基準年、2031年を予測年とみなします。また、2023年～2031年の世界の心臓再同期療法システム市場の複合年間成長率（CAGR %）も提供しています。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、心臓再同期療法システム市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界の心臓再同期療法システム市場の競合情勢を詳しく掘り下げています。世界の心臓再同期療法システム市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の心臓再同期療法システム市場企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測（2017年～2031年）

第5章 重要な洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主な合併と買収
  • COVID-19パンデミックが業界に与える影響

第6章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：製品タイプ別（2017年～2031年）
    • 心臓再同期療法ペースメーカー
    • 心臓再同期療法除細動器
  • 市場魅力度分析：製品タイプ別

第7章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別（2017年～2031年）
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第8章 北米市場の分析と予測

第9章 欧州市場の分析と予測

第10章 アジア太平洋市場の分析と予測

第11章 ラテンアメリカ市場の分析と予測

第12章 中東・アフリカ市場の分析と予測

第13章 競合情勢

  • 市場企業：競合マトリクス（企業階層・規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • Medtronic
    • Boston Scientific Corporation
    • Abbott
    • LivaNova PLC
    • BIOTRONIK SE &Co. KG
    • Asahi Kasei Medical Co., Ltd.
    • NIHON KOHDEN CORPORATION
    • Schiller AG
図表

List of Tables

  • Table 01: Global Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 03: North America Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 04: North America Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 05: Europe Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 06: Europe Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: Asia Pacific Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: Asia Pacific Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 09: Latin America Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Latin America Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 11: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Product Type, 2017-2031

List of Figures

  • Figure 01: Global Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Cardiac Resynchronization Therapy Systems Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 03: Global Cardiac Resynchronization Therapy Systems Market Value Share, by Product Type, 2022
  • Figure 04: Global Cardiac Resynchronization Therapy Systems Market Value Share, by Region, 2022
  • Figure 05: Global Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 06: Global Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 07: Global Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 08: Global Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 09: Global Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 10: North America Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 11: North America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 12: North America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 13: North America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 14: North America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 15: Europe Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 16: Europe Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 17: Europe Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 18: Europe Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 19: Europe Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 20: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 21: Asia Pacific Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 22: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 23: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 24: Asia Pacific Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 25: Latin America Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 26: Latin America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 27: Latin America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 28: Latin America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 29: Latin America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 30: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 31: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 32: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 33: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 34: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type, 2023-2031
目次
Product Code: TMRGL40463

Cardiac Resynchronization Therapy Systems Market - Scope of Report

TMR's report on the global cardiac resynchronization therapy systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global cardiac resynchronization therapy systems market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cardiac resynchronization therapy systems market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cardiac resynchronization therapy systems market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cardiac resynchronization therapy systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cardiac resynchronization therapy systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cardiac resynchronization therapy systems market.

The report delves into the competitive landscape of the global cardiac resynchronization therapy systems market. Key players operating in the global cardiac resynchronization therapy systems market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cardiac resynchronization therapy systems market profiled in this report.

Key Questions Answered in Global cardiac resynchronization therapy systems Market Report:

  • What is the sales/revenue generated by cardiac resynchronization therapy systems across all regions during the forecast period?
  • What are the opportunities in the global cardiac resynchronization therapy systems market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cardiac Resynchronization Therapy Systems Market - Research Objectives and Research Approach

The comprehensive report on the global cardiac resynchronization therapy systems market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cardiac resynchronization therapy systems market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cardiac resynchronization therapy systems market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiac Resynchronization Therapy Systems Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cardiac Resynchronization Therapy Systems Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Cardiac Resynchronization Therapy Systems Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Cardiac Resynchronization Therapy Pacemaker
    • 6.3.2. Cardiac Resynchronization Therapy Defibrillator
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Cardiac Resynchronization Therapy Systems Market Analysis and Forecast, by Region

  • 7.1. Key Findings
  • 7.2. Market Value Forecast, by Region, 2017-2031
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. Market Attractiveness Analysis, by Region

8. North America Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 8.1. Introduction
  • 8.2. Key Findings
  • 8.3. Market Value Forecast, by Product Type, 2017-2031
    • 8.3.1. Cardiac Resynchronization Therapy Pacemaker
    • 8.3.2. Cardiac Resynchronization Therapy Defibrillator
  • 8.4. Market Value Forecast, by Country, 2017-2031
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Product Type
    • 8.5.2. By Country

9. Europe Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. Key Findings
  • 9.3. Market Value Forecast, by Product Type, 2017-2031
    • 9.3.1. Cardiac Resynchronization Therapy Pacemaker
    • 9.3.2. Cardiac Resynchronization Therapy Defibrillator
  • 9.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 9.4.1. Germany
    • 9.4.2. U.K.
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product Type
    • 9.5.2. By Country/Sub-region

10. Asia Pacific Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product Type, 2017-2031
    • 10.3.1. Cardiac Resynchronization Therapy Pacemaker
    • 10.3.2. Cardiac Resynchronization Therapy Defibrillator
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product Type
    • 10.5.2. By Country/Sub-region

11. Latin America Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product Type, 2017-2031
    • 11.3.1. Cardiac Resynchronization Therapy Pacemaker
    • 11.3.2. Cardiac Resynchronization Therapy Defibrillator
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product Type
    • 11.5.2. By Country/Sub-region

12. Middle East & Africa Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product Type, 2017-2031
    • 12.3.1. Cardiac Resynchronization Therapy Pacemaker
    • 12.3.2. Cardiac Resynchronization Therapy Defibrillator
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of Middle East & Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product Type
    • 12.5.2. By Country/Sub-region

13. Competition Landscape

  • 13.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 13.2. Market Share Analysis, by Company (2022)
  • 13.3. Company Profiles
    • 13.3.1. Medtronic
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio
      • 13.3.1.3. SWOT Analysis
      • 13.3.1.4. Financial Overview
      • 13.3.1.5. Strategic Overview
    • 13.3.2. Boston Scientific Corporation
      • 13.3.2.1. Company Overview
      • 13.3.2.2. Product Portfolio
      • 13.3.2.3. SWOT Analysis
      • 13.3.2.4. Financial Overview
      • 13.3.2.5. Strategic Overview
    • 13.3.3. Abbott
      • 13.3.3.1. Company Overview
      • 13.3.3.2. Product Portfolio
      • 13.3.3.3. SWOT Analysis
      • 13.3.3.4. Financial Overview
      • 13.3.3.5. Strategic Overview
    • 13.3.4. LivaNova PLC
      • 13.3.4.1. Company Overview
      • 13.3.4.2. Product Portfolio
      • 13.3.4.3. SWOT Analysis
      • 13.3.4.4. Financial Overview
      • 13.3.4.5. Strategic Overview
    • 13.3.5. BIOTRONIK SE & Co. KG
      • 13.3.5.1. Company Overview
      • 13.3.5.2. Product Portfolio
      • 13.3.5.3. SWOT Analysis
      • 13.3.5.4. Financial Overview
      • 13.3.5.5. Strategic Overview
    • 13.3.6. Asahi Kasei Medical Co., Ltd.
      • 13.3.6.1. Company Overview
      • 13.3.6.2. Product Portfolio
      • 13.3.6.3. SWOT Analysis
      • 13.3.6.4. Financial Overview
      • 13.3.6.5. Strategic Overview
    • 13.3.7. NIHON KOHDEN CORPORATION
      • 13.3.7.1. Company Overview
      • 13.3.7.2. Product Portfolio
      • 13.3.7.3. SWOT Analysis
      • 13.3.7.4. Financial Overview
      • 13.3.7.5. Strategic Overview
    • 13.3.8. Schiller AG
      • 13.3.8.1. Company Overview
      • 13.3.8.2. Product Portfolio
      • 13.3.8.3. SWOT Analysis
      • 13.3.8.4. Financial Overview
      • 13.3.8.5. Strategic Overview